Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial

100

Citations

24

References

2020

Year

Esper G. Kallás, Alexander Roberto Precioso, Ricardo Palácios, Beatriz Thomé, Patricia Emília Braga, Tázio Vanni, Lúcia Maria Arruda Campos, Lílian Pereira Ferrari, Gabriella Mondini, Maria da Graça Salomão,

The Lancet Infectious Diseases

VaccinationVaccine SafetyPlacebo-controlled Phase 2Vaccine DevelopmentGlobal HealthMedicineVector Borne Disease

References

	Year	Citations

Page 1